Senti Biosciences Holdings and Celadon Partners SPV 35 Limited
Senti Biosciences Holdings reports merger agreement involving Celadon Partners SPV 35 Limited with $60 million contingent value right
Company-confirmed: reported in the company's own SEC filing
Latest update Sep 2, 2026, 4:29 PM ET
- 1Announced
- 2Pending
- 3Completed
Acquirer
Celadon Partners SPV 35 LimitedNot US-listed- Deal value
- $60M
- as stated in the filing
- Offer
- Not disclosed
- Premium
- N/A
- Shown only for a signed all-cash price per share
- Expected close
- Not disclosed
- merger
Share prices around the disclosure
Daily closes, each set to 100 on the first day shown. The dashed lines mark the session that first reflects each public event.
